HerbClinical dose · 300–450mg/day (standardised to 55% bacosides)Onset · 8–12 weeks of consistent use (most positive trials ran 12 weeks)

Bacopa Monnieri

Name: Bacopa Monnieri — Human Clinical Effect Matrix
Creator: The Nootropic Lab
License: https://creativecommons.org/licenses/by/4.0/

A meta-analysis of 9 RCTs (Kongkeaw et al., 2014, n=518) found Bacopa shortened Trail Making B and choice reaction times versus placebo, and two 12-week RCTs in healthy older adults (Calabrese 2008; Morgan & Stevens 2010) improved delayed word recall at 300mg/day. The newest 12-week RCT (Lopresti 2025, n=101, 300mg/day) found no effect on verbal learning, attention or working memory, though it did reduce self-reported stress. A 2026 network meta-analysis of 29 RCTs found ≥600mg/day beat 300–450mg/day for working memory. Best evidence is for delayed recall rather than acute effects.

By The Nootropic Lab editorial teamUpdated Oct 9, 20268 min read✓ Fact-checked

Evidence reviewed: Sep 28, 2026

Mechanism of action

Bacopa enhances synaptic communication by increasing dendritic branching and synaptic density. Its active compounds (bacosides A and B) facilitate repair of damaged neurons and upregulate antioxidant activity, reducing oxidative stress in hippocampal tissue. It also modulates serotonin and acetylcholine systems.

Clinical evidence summary

Human effect matrix

Based on human clinical trials only. Animal and in-vitro data excluded.

Effect	Evidence	Magnitude	Studies	Notes
Memory Consolidation	strong	Moderate	4	Kongkeaw 2014 meta-analysis (9 RCTs), two 12-week RCTs on delayed recall, and a 2026 network meta-analysis (working memory, ≥600mg/day). The 2025 Lopresti RCT at 300mg/day did not replicate the memory benefit.
Anxiety Reduction	moderate	Moderate	2	Calabrese 2008: anxiety fell with Bacopa and rose with placebo over 12 weeks; Lopresti 2025: lower self-reported stress reactivity.
Attention	mixed	Small	2	Positive pooled speed-of-attention result (Kongkeaw 2014) but no effect on attention in the largest recent RCT (Lopresti 2025, p=0.713).
Processing Speed	mixed	Small	2	An acute 320mg dose improved sustained task performance (2012), but the 2026 network meta-analysis found no processing-speed difference. Some users report temporary initial slowing.

Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results

Documented benefits

Delayed recall in healthy older adults (12-week RCTs)
Anxiety and stress reduction
Antioxidant activity (laboratory studies)

Side effects & cautions

GI effects (increased stool frequency, abdominal cramps, nausea) reported at 300mg/day in a 12-week RCT in older adults — take with food
More self-reported adverse reactions than placebo (digestive complaints, headaches) in a 2025 12-week RCT
Slowed information processing initially
Not recommended during pregnancy (precautionary: no human safety data)

How to take

Dosage300–450mg/day (standardised to 55% bacosides) — the classic trial dose; ≥600mg/day is an emerging, less-established option

TimingWith your largest meal of the day — morning or evening both work

With foodBacosides are fat-soluble, so a meal with some fat is the standard advice. Taking it with food also helps with the GI side effects reported in trials. Do not take on an empty stomach.

FormsCapsule is most practical. Powder has a bitter, unpleasant taste. Look for standardisation to at least 40–55% bacosides on the label — unstandardised herbal products may contain very little active compound.

Stacking recommendations

Ingredients that pair well with Bacopa Monnieri and why.

Lion's Mane

The definitive long-term memory stack. Bacopa improves synaptic density and memory consolidation; Lion's Mane drives NGF synthesis and neuroprotection. Both are slow-acting and complement each other without overlap.

Citicoline

Citicoline provides the acute focus and acetylcholine boost that Bacopa lacks in the short term, while Bacopa handles long-term memory consolidation. A well-rounded pairing found in Mind Lab Pro.

L-Theanine

Both have anxiolytic properties. L-Theanine provides immediate calm focus; Bacopa builds long-term stress resilience. The combination is gentle and well-tolerated.

Frequently asked questions

Why do some people feel "foggy" when starting Bacopa?

A minority of users experience a temporary initial slowing of mental processing — sometimes called the "Bacopa fog." This is linked to the serotonin modulation and typically resolves after 3–4 weeks. It reflects the herb's mechanism working, not a problem. If it persists past 6 weeks, reduce your dose.

Do I really need to take it with fat?

It is the sensible default. Bacosides are fat-soluble compounds, and GI side effects (cramps, nausea, more frequent stools) were reported in trials, so taking Bacopa with a normal meal that contains some fat is the usual advice.

What percentage of bacosides should I look for?

Aim for 40–55% bacosides standardisation. The two most-studied commercial extracts (Bacognize and Synapsa) are both standardised. Generic "Bacopa" with no standardisation stated is unreliable — the active compound content may be negligible.

How long does it take to work?

The positive memory trials measured outcomes after 12 weeks. This is not a supplement you evaluate in the first month. Set a calendar reminder to assess at around 12 weeks — and note that the newest 12-week trial at 300mg/day found no cognitive benefit, so results vary.

Can Bacopa be taken long-term?

Most trials ran 12 weeks or less, so controlled data beyond that is thin. Traditional Ayurvedic use is continuous without cycling, and no trial has shown cycling is necessary — but long-term safety has not been studied directly.

Top stacks containing Bacopa Monnieri

Mind Lab Pro

9.4/10

Opti-Nutra

Editor's Choice

NooCube

7.6/10

Wolfson Brands

Alpha Brain

6.6/10

Onnit

Bacopa Monnieri in Southeast Asia

Bacopa monnieri is not named individually in the FDA Philippines, Thai FDA, NPRA and ASEAN documents cited below, though as a botanical/herbal extract it falls within the general categories each regulator uses for plant-derived health-supplement ingredients. The Philippines' FDA and Thailand's FDA each define food/dietary supplement ingredients to include herbs or plant-derived substances as a category, while Malaysia's NPRA guideline describes substances derived from natural sources … botanical materials in the forms of extracts, isolates, concentrates as an accepted ingredient class. None of the documents cited below names Bacopa monnieri as prohibited or restricted.

The botanical-ingredient pathway Bacopa falls under

The Philippines' FDA Circular No. 2025-001 defines a food/dietary supplement as containing "one or more of the following dietary ingredients: vitamin, mineral, amino acid, herb, or other dietary substance of botanical, animal, artificial or natural origin," naming herb as an accepted category that covers a botanical extract such as Bacopa monnieri. Thailand's Notification No. 293 defines eligible substances to include "produces obtained from plants or animals" and their "concentrates, metabolites composition or extracts," a category that likewise covers a standardised Bacopa extract. Where Bacopa is not one of the substances a regulator has already prescribed, general documentation and label-approval rules apply instead of a Bacopa-specific notification.

Products in Southeast Asia

HSA / NPRA / BPOM / FDA PH / Thai FDA

Is Bacopa monnieri named specifically on Thailand's food supplement framework?

A Bacopa-specific listing was not found. Thailand's Notification No. 293 defines the eligible ingredient categories broadly — including "produces obtained from plants or animals" and their "concentrates, metabolites composition or extracts" — rather than naming individual botanicals, so a Bacopa product not already prescribed follows the notification's general label-approval submission route.

How does Malaysia's NPRA categorise a botanical extract like Bacopa monnieri?

NPRA's health-supplement page describes an accepted ingredient category as "substances derived from natural sources, including animal, mineral and botanical materials in the forms of extracts, isolates, concentrates, metabolite," which covers a standardised Bacopa monnieri extract. A Bacopa product is checked against NPRA's product-search database rather than a separate botanical-specific list.

SEA country guides

Sources: FDA Philippines — Circular No. 2025-001, Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults · Thai FDA — Notification of Ministry of Public Health (No. 293) B.E.2548 (2005) Re: Food Supplement · NPRA — Health Supplement Main Page · HSA — Guidelines on Prohibited and Restricted Ingredients in Health Supplements and Traditional Medicines (Oct 2025) · ASEAN — Guiding Principles for Inclusion into or Exclusion from the Negative List of Substances for Health Supplements

Regulatory note

Health supplements in Singapore are regulated by the Health Sciences Authority (HSA); in Malaysia by the National Pharmaceutical Regulatory Agency (NPRA); in Indonesia by the Badan Pengawas Obat dan Makanan (BPOM); in the Philippines by FDA Philippines; in Thailand by FDA Thailand. Halal certification is required by law for supplements marketed to Indonesian consumers from 18 October 2026, regulated by the Badan Penyelenggara Jaminan Produk Halal (BPJPH); in Malaysia, products described as halal must be certified, with the Jabatan Kemajuan Islam Malaysia (JAKIM) as the certifying body. We surface certification status per product where verifiable. This page is editorial, not medical advice. Consult a qualified healthcare professional before starting any supplement.

Sources (6)expand

← Back to Ingredients Guide